Under CollPlant’s (CLGN) existing development and commercialization agreement, CollPlant has granted AbbVie (ABBV) a worldwide exclusive ...
Collaboration will combine AbbVie’s oncology expertise and Xilio’s proprietary tumor-activation technology to develop novel immunotherapies, ...
AbbVie's combination antibiotic Emblaveo has gotten federal approval to treat complicated intra-abdominal infections, making it the first and only such therapy approved to fight antimicrobial ...
This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...
AbbVie's $10.1 billion takeover of ImmunoGen has been rewarded with EU approval for Elahere, the first drug specifically cleared for folate receptor-alpha (FRα) positive, platinum-resistant ...
After hours: 7:54:48 p.m. EST ...
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
After hours: February 7 at 7:54:48 PM EST ...
* EPS estimates are Normalized unless otherwise noted.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback